Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationTissue DonorsPeripheral Blood Stem Cell TransplantationStem CellsGraft SurvivalHistocompatibility TestingLeukemiaBusulfanLiver TransplantationTreatment OutcomeHistocompatibilityHematopoiesisKidney TransplantationAnemia, AplasticRecurrenceImmunosuppressive AgentsCord Blood Stem Cell TransplantationRetrospective StudiesCombined Modality TherapyTransplantation, IsogeneicRemission InductionHematopoietic Stem Cell MobilizationCyclophosphamideGraft vs Leukemia EffectAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseTime FactorsMyeloablative AgonistsGraft RejectionMice, Inbred C57BLChimerismTransplantation ImmunologyBone and BonesHLA AntigensHematologic DiseasesCell DifferentiationMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaSevere Combined ImmunodeficiencyBone Marrow PurgingSurvival RateHeart TransplantationMultiple MyelomaGraft vs Tumor EffectLymphocyte TransfusionImmunosuppressionCell TransplantationColony-Forming Units AssayDisease-Free SurvivalLymphocyte DepletionAcute DiseaseMesenchymal Stem Cell TransplantationFlow CytometryMelphalanCytomegalovirus InfectionsT-LymphocytesLung TransplantationLymphoma, Non-HodgkinCell LineageBone Marrow DiseasesLeukemia, MyeloidFollow-Up StudiesGranulocyte Colony-Stimulating FactorSiblingsRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsVidarabineAntilymphocyte SerumTransplantationCyclosporineUnrelated DonorsCells, CulturedSalvage TherapyOrgan TransplantationFetal BloodOpportunistic InfectionsCell SeparationStem Cell NicheCytarabineImmunocompromised HostPrognosisEmbryonic Stem CellsLymphoproliferative DisordersLiving DonorsAdult Stem Cells